Loading song details...
James McCloskey MD Regarding Molecular Testing In Acute Myelogenous Leukemia
No description available.
MP3 Download
Video Download
Related Songs
3:36
Managing Comorbidities In AML
0:57
James McCloskey MD Speculates On The Reliability Of Companion Diagnostic Test For FLT3
0:35
James McCloskey MD Describes How The FLT3 Mutation Influences Treatment Decisions In AML
0:55
James McCloskey MD Regarding Molecular Testing In Acute Myelogenous Leukemia
1:26
James McCloskey MD Speculates On The Landscape Of MDS As A Result Data Presented At ASH 19
1:26
James McCloskey MD Considers How The Role Of Molecular Profiling In AML Is Changing
1:10
James McCloskey MD Elaborates On The Role Of Molecular Testing In Newly Diagnosed AML
1:25
James McCloskey MD Considers The Application Of FLT3 Test In Newly Diagnosed AML Patients
2:15
Dr McCloskey Discusses IDH Inhibitors In AML
1:38
James McCloskey MD Shares His Impression Of The Phase 3 ASCERTAIN Trial In MDS
1:47
James McCloskey MD Regarding The QUASAR 001 Study Presented At ASH 2019
1:19:24
COVID 19 And Cancer Care A Webinar Without Walls Lecture Series
1:44
Dr McCloskey On The Results Of ASCERTAIN Trial In MDS
5:20
Case Based Overview De Novo Acute Myeloid Leukemia
3:10
Case 1 FLT3 AML
1:10
Dr McCloskey Discusses Targeting CD19 In B Cell ALL
0:52
James McClosky MD On Using Newly FDA Approved Gilteritinib For Patients With AML
3:33
Selecting Therapy For Newly Diagnosed AML
3:30